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Abstract
Objective To estimate the contributions of biological aging, historical
trends, and birth cohort effects on trends in pre-eclampsia in the United
States.
Design Population based retrospective study.
Setting National hospital discharge survey datasets, 1980-2010, United
States.
Participants 120 million women admitted to hospital for delivery.
Main outcomemeasures Temporal changes in rates of mild and severe
pre-eclampsia in relation to maternal age, year of delivery, and birth
cohorts. Poisson regression as well as multilevel age-period-cohort
models with adjustment for obesity and smoking were incorporated.
Results The rate of pre-eclampsia was 3.4%. The age-period-cohort
analysis showed a strong age effect, with women at the extremes of
maternal age having the greatest risk of pre-eclampsia. In comparison
with women delivering in 1980, those delivering in 2003 were at 6.7-fold
(95% confidence interval 5.6-fold to 8.0-fold) increased risk of severe
pre-eclampsia. Period effects declined after 2003. Trends for severe
pre-eclampsia also showed a modest birth cohort effect, with women
born in the 1970s at increased risk. Compared with women born in 1955,
the risk ratio for women born in 1970 was 1.2 (95% confidence interval
1.1 to 1.3). Similar patterns were also evident for mild pre-eclampsia,
although attenuated. Changes in the population prevalence of obesity
and smoking were associated with period and cohort trends in
pre-eclampsia but did not explain the trends.
Conclusions Rates of severe pre-eclampsia have been increasing in
the United States and age-period-cohort effects all contribute to these
trends. Although smoking and obesity have driven these trends, changes
in the diagnostic criteria may have also contributed to the
age-period-cohort effects. Health consequences of rising obesity rates
in the United States underscore that efforts to reduce obesity may be
beneficial to maternal and perinatal health.
Introduction
Pre-eclampsia is a pregnancy specific, multisystem syndrome
characterized by reduced organ perfusion secondary to
vasospasm and activation of the coagulation cascade. The
condition complicates about 3-6% of pregnancies, with a
1.5-fold to 2-fold higher incidence in first pregnancies.1-4 The
syndrome of pre-eclampsia is associated with high risks of
preterm delivery, intrauterine growth restriction, placental
abruption, and perinatal mortality.5-8Additionally, pre-eclampsia
serves as a sentinel marker for women who will experience
premature cardiovascular and cerebrovascular diseases and other
chronic illnesses later in life.9 10 Despite extensive research, the
cause of pre-eclampsia remains elusive.11
The prevalence of pre-eclampsia has shown noticeable variation
over time, leading to speculations that population level
distribution of risk factors may have influenced these trends.
Age-period-cohort analysis is a classic approach to understand
how and why disease trends change over time. Pre-eclampsia
has increased in both the youngest and the oldest women of
reproductive age12 and the prevalence in the United States has
increased from 2.5% in 1987 to 3.2% in 2004.13 This increase
may be influenced by a variety of factors. For example, increases
may be across age groups, indicative of a period effect, due to
factors such as changes in the diagnostic criteria or earlier
identification of symptoms during pregnancy. Although
plausible, the influence of maternal birth cohorts remains
unexplored.Women born in “older” cohorts may have different
lifestyle factors (for example, smoking or illicit drug use) than
women born in the more recent cohorts. Given that obesity is
one of the strongest risk factors for pre-eclampsia14 15 higher
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rates of pre-eclampsia in populations with higher proportions
of obese womenwould be expected. If population level variation
in obesity differs by both age and time period, as it does in the
United States,16 then a birth cohort effect explaining trends over
time may arise. Substantial research has indicated the presence
of cohort effects in obesity rates over time, suggesting that such
cohort effects may then extend to cohort effects in
pre-eclampsia.17-19 In contrast, smoking during pregnancy is
associated with a reduced risk of pre-eclampsia.20The prevalence
rate of smoking has been declining in the United States,21 and
evidence indicates that both period and cohort effects may be
underlying smoking trends in the United States.22 23 Taken
together, increases in obesity and decreases in smoking
prevalence could lead to an increase in pre-eclampsia rates.
We examined pre-eclampsia rates for three different timescales,
maternal age (time between maternal birth and disease
diagnosis), period (time of occurrence of disease), and maternal
birth cohort (time of mother’s birth). The goal of this analysis
was to understand the complex associations of maternal age,
trends in prevalence, and cohort trajectories—all operating on
a single timescale—on pre-eclampsia. We hypothesized that
birth cohort effects may be responsible for increases in
pre-eclampsia rates, given the increase in obesity among more
recently born cohorts of women, as well as a decline in smoking
rates. This population based study is based on births in the
United States spanning three decades, 1980 through 2010.
Methods
Study design and data sources
We utilized the 1980-2010 national hospital discharge survey
datasets, assembled by the US Centers for Disease Control and
Prevention. Non-federal general and specialty short stay
hospitals in the United States participated in the survey.24 We
restricted the analysis only to hospital admissions that resulted
in childbirth. The data included in the analysis are representative
of hospital discharges in the 50 states and District of Columbia
that resulted in childbirth.
Between 1980 and 1987 the survey used a two stage stratified
sampling design; since 1988 the survey used a modified three
stage design.25 The number of hospitals surveyed each year
ranged between 400 and 558. Beginning in 2008, the number
of hospitals chosen for the survey was reduced by half (roughly
200 to 300 hospitals.)
Classification and diagnosis of pre-eclampsia
The diagnosis of pre-eclampsia was based on the
recommendations of the National High Blood Pressure
Education Program Working Group.26 Mild pre-eclampsia was
defined as a blood pressure ≥140/90 mm Hg systolic/diastolic
occurring at ≥20 weeks’ gestation and associated with the new
onset of ≥300 mg protein in a 24 hour maternal urine collection
or 1+ protein on a urine dipstick. Severe pre-eclampsia was
defined as one of the following: blood pressures ≥160 mm Hg
systolic or ≥110 mm Hg diastolic assessed at least twice over
a six hour window; new onset proteinuria of ≥5000 mg in a 24
hour period; oliguria <500 mL in 24 hours; cerebral or visual
disturbances, pulmonary edema, or cyanosis; epigastric/upper
quadrant pain; impaired liver function, thrombocytopenia, or
intrauterine growth restriction.27 Since the number of women
with a diagnosis of eclampsia was too few, we combined
eclampsia cases with those of severe pre-eclampsia. All
diagnoses and procedures were coded based on the international
classification of disease, ninth revision, clinical modification
(ICD-9-CM). The ICD-9-CM codes that were used to abstract
data on mild and severe pre-eclampsia and eclampsia were
642.4, 642.5, and 642.6, respectively.
Cohort composition
We applied analytic weights contained in the national hospital
discharge survey data based on the inverse of the probability
that a US hospital was selected into the survey sample in each
year of the data collection. Approximately 3.6 to 4.0 million
hospital admissions resulted in childbirths each year, yielding
a weighted total of about 120 million births between 1980 and
2010. These sampling weights were applied to produce national
estimates and to consequently reflect generalizability of the
findings.28 Of these births, we excluded women who were ≥46
years of age (n=54 624), and women born either before 1940
(n=33 713) or during 1994 or later (n=62 057). These exclusions
were necessary to ensure stability in the estimation of
age-period-cohort effects. We also excluded women with a
diagnosis of chronic hypertension (n=876 484), chronic
hypertension with superimposed pre-eclampsia (n=288 290),
and gestational hypertension (n=2 398 404).
Period and cohort level covariates
We obtained the yearly prevalence of any current smoking as
well as obesity (body mass index ≥30) by maternal age among
US women in the national health interview survey,29 a cross
sectional, nationally representative household survey conducted
between 1986 and 2010. Yearly estimates of obesity prevalence
for women increased from 21.7% in 1986 to 36.0% in 2010,
while smoking amongUS adults decreased from 30.3% in 1987
to 18.7% in 2010.
Age-period-cohort models
We modeled age-period-cohort effects (in single years) on
pre-eclampsia from 1980 to 2010. Since an individual’s birth
cohort is determined by the time period of study and the
individual’s age (that is, cohort=period-age), standard regression
models to simultaneously estimate the additive effects of age,
period, and cohort effects cannot achieve a unique solution.30 31
We used two approaches to age-period-cohort analysis to
provide a robust check on results. Our first approach to
overcome the dependency was to estimate a variable for the
overall linear trend in pre-eclampsia rates, which cannot be
attributable uniquely to period or cohort effects but instead
reflects the sum of linear period and cohort effects. This is
referred to as a “drift” variable.32-34 Deviations from linearity
(termed curvature), which can be uniquely attributable to period
or cohort effects and are not dependent on any model constraint,
are then estimated as period and cohort effects. We estimated
pre-eclampsia rates using parametric smooth functions based
on natural splines35 with five knots each for age, period, and
cohort variables to detect non-linear effects. Modeling was
carried out using the apc.fit function in the Epi package36 in the
R program (version 2.14.2), with 1955 as the cohort referent
and 1980 as the period referent group.We determined all models
a priori and sequentially fit them beginning with age only, and
then adding drift and other variables.
We also examined if other covariates affected the overall
age-period-cohort analysis. Specifically, we used cross classified
random effects, multilevel Poisson regression models.37 This
model estimates a regression of log rates of pre-eclampsia on
an intercept and age (categorised as <20, 20-24, 25-29, and
30-45 years). We then estimated a second order regression of
variation in the intercept across a set of period and cohort levels.
We used two covariates: the prevalence of obesity and the
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prevalence of smoking by age among women. Period specific
and cohort specific prevalence was entered in separate models
due to collinearity and different years of data coverage
(1986-2010 for obesity and 1987-2010 for smoking). We fit the
multilevel models in SAS (version 9.3). The supplementary file




Figure 1⇓ shows the prevalence of all pre-eclampsia and those
of mild and severe pre-eclampsia between 1980 and 2010. For
any pre-eclampsia, the rate increased from 3.4% in 1980 to 3.8%
in 2010. This increase is driven by severe pre-eclampsia; the
rate increased from 0.3% in 1980 to 1.4% in 2010, a relative
increase of 322%. In contrast, the prevalence rate of mild
pre-eclampsia declined by 19%, from 3.1% in 1980 to 2.5% in
2010 (perhaps reflecting a shift from the mild to severe
pre-eclampsia).
Maternal age specific trends in pre-eclampsia
Tables 1⇓ and 2⇓ show age specific trends in the prevalence of
mild and severe pre-eclampsia, respectively; supplementary
tables 1 and 2 show the corresponding data on the number of
cases of mild and severe pre-eclampsia. The rate of mild
pre-eclampsia decreased by period among women aged <30
years (for instance, among 15-19 year old women the rate
dropped from 4.0% in 1980 to 2.8% in 2010), whereas the rate
increased by period among older women (among 30-34 year
old women, for instance, the rate increased from 1.7% in 1980
to 2.0% in 2010). In contrast, the rate of severe pre-eclampsia
showed a consistent temporal increase by period within every
maternal age group (table 2.)
Age-period-cohort effects on pre-eclampsia
Figures 2⇓ and 3⇓ show the model derived age-period-cohort
effects on mild and severe pre-eclampsia, respectively. For mild
pre-eclampsia, there is evidence of a cohort effect, with cohorts
born around 1970 at an especially higher risk for mild
pre-eclampsia (fig 2). For severe pre-eclampsia, women born
in more recent cohorts have a higher risk (fig 3). Age effects
show a J-shaped curve, with the highest risk at the extremes of
the age distribution. There is evidence of an increasing period
effect for both mild and severe pre-eclampsia, especially during
the 1990s, and then a decrease in the period effect curvature in
the late 2000s. This indicates that the slope of the period effect
sharply increased in the 1980s and 1990s and began to decline
thereafter.
For both mild and severe pre-eclampsia, the period effect
estimate shows a decrease in curvature during a period when
the underlying rate was increasing, especially for severe
pre-eclampsia. This suggests that while rates of severe
pre-eclampsia increased across women of all ages in the 1980s
and 1990s, the rates increased primarily in younger women in
the 2000s. This is consistent with the data shown in table 2. For
example, the rate of severe pre-eclampsia increased 5.7-fold
between the 1957 and 1987 central birth cohorts for women
aged 20-24 years but only 2.3-fold among those aged 40-45.
Thus, younger birth cohorts of women primarily drove increases
in the rate of severe pre-eclampsia in the 2000s.
Multilevel modeling of period and cohort
effects
Supplementary figures 1 and 2 show the results of multilevel
age-period-cohort models for mild and severe pre-eclampsia,
respectively, with birth cohort and period as random intercept
terms. This includes period specific and cohort specific
prevalence of smoking and obesity in the United States as
covariates of period and cohort effects. Results were similar to
the analysis described in figure 2. The overall period and cohort
effects remained robust after adjustments for smoking and
obesity prevalence by period and cohort, suggesting that these
factors do not completely explain the observed period and cohort
effects for both mild and severe pre-eclampsia.
Discussion
Temporal changes in rates of pre-eclampsia in the United States
over three decades highlight four important findings. Although
the rate of pre-eclampsia increased, two forces contributed
simultaneously to this increase. Firstly, these data support our
hypothesis that cohort effects in obesity may, at least partially,
be responsible for increases in pre-eclampsia. Women born in
the mid-1970s were at an increased risk for mild pre-eclampsia,
whereas women born in the more recent periods showed an
increased risk of severe pre-eclampsia, suggesting a birth cohort
effect. Secondly, and contrary to our hypothesis, we observed
a strong period effect, indicating that the rate of pre-eclampsia
increased across all maternal ages. After the late 1990s and early
2000s, the magnitude of the period effect declined, which likely
indicates that young women were at higher risk for developing
pre-eclampsia. Thirdly, and as expected, these data showed
increased pre-eclampsia rates among young and older women.
Fourthly, declines in smoking prevalence in the United States
are associated with increases in the period effect for mild and
severe pre-eclampsia. In contrast, increases in the prevalence
of obesity in the United States are associated with increases in
the cohort effect, especially for severe pre-eclampsia. Overall,
these results suggest that changes in the population proportion
smoking during pregnancy impact on pre-eclampsia rates across
age, whereas changes in obesity by cohort influence severe
pre-eclampsia in younger cohorts only.
Limitations of this study
Geographic variations in the prevalence of pre-eclampsia in the
United States are widespread, with states in the south showing
higher rates than in other parts of the country,13 and our analysis
does not take into account the regional disparity. Confounding
by maternal sociodemographic and behavioural factors may
have influenced our findings to some extent. Some of the factors
are either unavailable (for example, parity, body mass index,
or smoking) or are poorly recorded (for example, a substantial
proportion of births are missing data on race/ethnicity) in the
survey. However, a subgroup analysis restricted to births where
maternal race was recorded yielded results similar to the overall
analysis (not shown). Nevertheless, static risk factors such as
race/ethnicity and the average number of births per woman
across the lifecourse are unlikely to influence the
age-period-cohort trends since such factors have remained fairly
constant over time. The possibility of women being pregnant
more than once over the study period cannot be overlooked and
our analyses do not take this into account.
Strengths of this study
This age-period-cohort analysis is the largest of any cohort
studies (120 million births) to understand temporal changes in
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the prevalence of pre-eclampsia in the United States. The
national hospital discharge survey data is arguably the most
ideal of all data sources in the United States to study temporal
changes of an obstetrical condition such as pre-eclampsia. The
validity in the diagnosis of pre-eclampsia is considered excellent
in the survey.38 39 The sensitivity and specificity for
pre-eclampsia on the hospital discharge summaries (validated
against chart abstraction of prenatal and medical and obstetrical
records) were 88% and 95%, respectively, while the positive
and negative predictive values were 91% and 98%,
respectively.39 None the less, we acknowledge the possibility
of somemisclassification of pre-eclampsia cases in the national
hospital discharge survey, although such misclassification is
likely to be small and non-differential in nature.
Two population level trends are associated with these period
and cohort changes: the prevalence of obesity (increasing
throughout the study period) was associated with an increasing
cohort effect for severe pre-eclampsia, and smoking (decreasing
throughout the study period) was associated with an increasing
period effect for both mild and severe pre-eclampsia, and an
increasing cohort effect for mild pre-eclampsia. Overweight
and obese women are susceptible to develop insulin
resistance,40 41 which in turn is implicated as a strong (and
modifiable) risk factor for pre-eclampsia.42 It is estimated that
being overweight or obese accounts for 15-17% of cases of
pre-eclampsia.43 Thus, the increases in the prevalence of obesity
in the United States have likely resulted, at least partly, in a
greater population burden of pre-eclampsia, especially among
women born in more recent birth cohorts. Further, while
smoking is a risk factor for many adverse pregnancy outcomes,44
it is associated with a lower risk for pre-eclampsia.20 42Decreases
in the prevalence of smoking in the population may also
contribute to a higher burden of pre-eclampsia. Another factor
that may have contributed to the increase in pre-eclampsia
includes metabolic disorders such as gestational diabetes,45
which has increased temporally in the United States. A
subanalysis restricted to women without any diabetes
(pregestational or gestational) was similar to the overall findings,
providing reassurance to the stability of our results.
Our results show that the risk of pre-eclampsia for birth cohorts
in the mid-1970s (women who would have borne children in
the 1990s) is higher than expected. Given the long term health
consequences of pre-eclampsia,9 10 46 women born in the
mid-1970s cohorts, who are now approaching middle age, may
be at particularly increased risk for adverse health outcomes
through the life course. Furthermore, the offspring of these
women should be carefully monitored for increases in adverse
health outcomes given the associations betweenmaternal obesity
in pregnancy and adverse health in offspring.
Maternal age, period, and birth cohort effects
In addition to smoking and obesity, at least one other factor may
partly help to explain the period and cohort effects we observed
for trends in pre-eclampsia. Specifically, the decline in the
period effect starting around 2003 may have to do with changes
in diagnostic criteria for pre-eclampsia. In 2002, the criteria for
the diagnosis of pre-eclampsia was revised by eliminating the
use of incremental increases in blood pressure since this
occurred in almost 25% of women.47 Therefore, the new and
stricter guidelines27 may have resulted in a decline in the
observed period effect in pre-eclampsia since the early 2000s.
In addition, an increased use of ultrasonography (to detect
intrauterine growth restriction, a clinical criterion for diagnosing
severe pre-eclampsia) may have also contributed to the temporal
increase in severe pre-eclampsia. However, the effect of
increased ultrasound use on temporal increase in severe
pre-eclampsia is likely small.
There may be other unmeasured causes of changes in rates of
pre-eclampsia, such as increased physician awareness or the
prevalence of routine testing. Although data are unavailable to
assess the contribution of such factors to trends in pre-eclampsia,
we note that, similar to changes in diagnostic criteria, they would
be unlikely to affect estimates of the cohort effect in
pre-eclampsia.
ANorwegian study48 reported an increase in pre-eclampsia from
2.0% in 1967-74 to 3.3% in 1998. However, the rate increased
to 4.4% in 1999 after the introduction of a revised notification
form to record the diagnosis of pre-eclampsia, but the rate fell
to 3.6% in 2008. Similar trends in pre-eclampsia rates have also
been observed in Australia, Canada, Denmark, Scotland, and
Sweden, and it has been speculated that an increase in rates of
early elective obstetric interventions may have led to a decline
in rates of pre-eclampsia since the early 2000s.49
Conclusions
Rates of severe pre-eclampsia are steadily increasing in the
United States. The analyses show strong period effects for the
temporal increase in pre-eclampsia up to the 1990s, but since
the early 2000s, age and birth cohort effects appear to be
primarily responsible for the increase. The trends for
pre-eclampsia are concurrent to decreases in smoking prevalence
and, more importantly, increases in the prevalence of obesity.
These trends in the prevalence of pre-eclampsia seem
biologically plausible, and may have social and behavioural
underpinnings.
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Tables
Table 1| Rates of mild pre-eclampsia (%) by selected maternal age, period, and central maternal birth cohorts in United States, 1980 to 2010
Central birth cohort
Maternal age (years)














The cohort follows from lower left to upper right, going diagonally.
See supplementary table 1 for number of mild pre-eclampsia cases for each of age-period cross classifications.
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The cohort follows from lower left to upper right, going diagonally.
Supplementary table 2 shows number of severe pre-eclampsia cases for each of age-period cross classifications.
*Number of severe pre-eclampsia cases <25 to produce stable estimates of rates.
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Figures
Fig 1 Temporal changes in prevalence of pre-eclampsia: United States, 1980 to 2010
Fig 2 Age-period-cohort influences on trends in mild pre-eclampsia: United States, 1980 to 2010. Open circles refer to
reference group for birth cohort and period. Adjusted risk ratio (red dot) for 1970 birth cohort (relative to reference cohort
1955) is 1.2 (95% confidence interval 1.1 to 1.2). Similarly, risk ratio (blue dot) for 2003 birth period (relative to reference
period 1980) is 1.7 (95% confidence interval 1.6 to 1.8). Small hash marks on bottom x-axis pertain to knot locations for
birth cohort, and hash marks on top axis refer to knot locations for period. Estimates for period effect are second order
derivatives, indicating that slope of period effect for mild pre-eclampsia has been decelerating since 2003
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Fig 3 Age-period-cohort influences on trends in severe pre-eclampsia: United States, 1980 to 2010. Open circles refer to
reference group for birth cohort and period. Adjusted risk ratio (red dot) for 1970 birth cohort (relative to reference cohort
1955) is 1.2 (95% confidence interval 1.1 to 1.3). Similarly, risk ratio (blue dot) for 2003 birth period (relative to reference
period 1980) is 6.7 (95% confidence interval 5.6 to 8.0). Small hash marks on bottom x axis pertain to knot locations for
birth cohort, and hash marks on top axis refer to knot locations for period. Estimates for period effect are second order
derivatives, indicating that slope of period effect for severe pre-eclampsia has been decelerating since 2003
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